Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mausam Patel

Concepts (75)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Scalp
1
2024
44
0.800
Why?
Brachytherapy
2
2020
51
0.790
Why?
SEER Program
5
2020
106
0.750
Why?
Carcinoma, Non-Small-Cell Lung
2
2025
175
0.740
Why?
Brain Neoplasms
2
2025
319
0.740
Why?
Glioblastoma
1
2022
101
0.660
Why?
Neoplasm Micrometastasis
1
2020
7
0.620
Why?
Prostatic Neoplasms
2
2020
401
0.620
Why?
Urethral Neoplasms
1
2019
6
0.610
Why?
Adenocarcinoma, Clear Cell
1
2019
35
0.590
Why?
Carcinoma, Signet Ring Cell
1
2018
14
0.570
Why?
Lung Neoplasms
2
2025
645
0.560
Why?
Adenocarcinoma
1
2020
405
0.480
Why?
Pancreatic Neoplasms
1
2018
219
0.480
Why?
Combined Modality Therapy
3
2020
640
0.390
Why?
Survival Rate
3
2020
949
0.380
Why?
Aged
7
2025
10430
0.340
Why?
Breast Neoplasms
1
2020
1223
0.330
Why?
Aged, 80 and over
5
2025
3495
0.330
Why?
Radiotherapy, Adjuvant
2
2020
65
0.310
Why?
Kaplan-Meier Estimate
2
2022
487
0.310
Why?
Survival Analysis
2
2022
659
0.300
Why?
United States
5
2024
5413
0.270
Why?
Neoplasm Staging
2
2020
774
0.260
Why?
Humans
13
2025
53246
0.250
Why?
Retrospective Studies
4
2024
6821
0.230
Why?
Cranial Irradiation
1
2025
25
0.230
Why?
Middle Aged
5
2024
13422
0.220
Why?
Adult
5
2024
14541
0.210
Why?
Hepatitis, Alcoholic
1
2024
12
0.210
Why?
Liver Diseases, Alcoholic
1
2024
35
0.200
Why?
Radiation Oncology
1
2023
26
0.200
Why?
Male
7
2025
27444
0.190
Why?
Female
7
2025
28792
0.180
Why?
Anticonvulsants
1
2022
134
0.170
Why?
Head and Neck Neoplasms
1
2024
292
0.160
Why?
Medicare
1
2022
280
0.160
Why?
Vesiculovirus
1
2020
6
0.160
Why?
Industry
1
2020
16
0.160
Why?
Patents as Topic
1
2020
10
0.160
Why?
Inventions
1
2020
9
0.160
Why?
Interferon-beta
1
2020
32
0.160
Why?
Neoplasm Recurrence, Local
1
2024
647
0.150
Why?
Disease-Free Survival
1
2020
466
0.150
Why?
Immunity, Innate
1
2020
112
0.150
Why?
Proportional Hazards Models
1
2020
445
0.150
Why?
Propensity Score
1
2020
170
0.140
Why?
Mastectomy
1
2020
147
0.140
Why?
Universities
1
2020
186
0.140
Why?
Florida
1
2018
70
0.140
Why?
Internship and Residency
1
2023
439
0.140
Why?
Cohort Studies
1
2020
1557
0.120
Why?
Treatment Outcome
2
2025
5597
0.100
Why?
Prognosis
1
2018
2118
0.100
Why?
Follow-Up Studies
1
2018
2318
0.100
Why?
Young Adult
1
2018
4514
0.070
Why?
Adolescent
1
2018
6912
0.060
Why?
Liver Cirrhosis, Alcoholic
1
2024
9
0.050
Why?
Faculty
1
2023
71
0.050
Why?
Radiotherapy Dosage
1
2024
249
0.050
Why?
Educational Status
1
2023
229
0.050
Why?
Radiotherapy, Intensity-Modulated
1
2024
181
0.050
Why?
Liver Cirrhosis
1
2024
246
0.040
Why?
Health Status Disparities
1
2024
221
0.040
Why?
Oncolytic Virotherapy
1
2020
28
0.040
Why?
Xenograft Model Antitumor Assays
1
2020
228
0.040
Why?
Radiotherapy
1
2020
126
0.040
Why?
CD8-Positive T-Lymphocytes
1
2020
145
0.040
Why?
CD4-Positive T-Lymphocytes
1
2020
166
0.040
Why?
Prospective Studies
1
2023
2412
0.030
Why?
Cell Proliferation
1
2020
1031
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2020
868
0.030
Why?
Cell Line, Tumor
1
2020
1470
0.030
Why?
Mice
1
2020
5982
0.020
Why?
Animals
1
2020
13528
0.010
Why?
Patel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description